In support, the neuroprotective actions of candesartan were reported to involve inhibition of ER stress in a rotenone model of Parkinson's disease in rats (53), potentially via inhibition of the ATF4-CHOP-Puma pathway. The gene discussed is ATF4; the disease is Parkinson disease.